← Map · Health Care Equipment · S&P 500
RMD RESMED
Connected therapy in the 10-K — not on the call
What they are doing
CAPA + connected sleep. The moat they claim lives in the FY2026 10-K: algorithm + cloud so fewer clinicians manage more patients. The year-end call was different: $1.57B FY (+11%), 5–7% core guide, Noctrix in, MatrixCare out, Astral pause. No adherence or patients-per-clinician number. Filing says the intelligence is in the product; the call did not prove it this quarter.
Why the score
- Reach 2 not 3: one therapy+cloud program.
- Weight 3 not 2: algorithm + cloud vs a dumb blower is a needle if it is real.
- Proof 2 not 3: filing names it. This quarter printed no patients-per-clinician or adherence number.
What would move it next quarter: Patients-per-clinician, adherence %, or digital attach said out loud.
Open these first
Evidence
ooking statements, and there can be no assurance that the forward-looking statements contained in this report will in fact occur. ITEM 1 BUSINESS General We are a global leader in digital health and cloud-connected medical devices. We design innovative technology to empower people to live happier, healthier lives. Our artificial intelligence, or AI, powered digital health ons. OSA has been recognized as a cause of hypertension and a significant comorbidity for heart disease, stroke, and type 2
ment. Accounting and practical expedient elections We have elected to account for shipping and handling activities associated with our Sleep and Breathing Health segment as a fulfillment cost within cost of sales, and record shipping and handling costs collected from customers in net revenue. We have also elected for all taxes assessed by government authorities elp physicians and providers better manage chronic disease and lower healthcare costs. For example, our newest device, AirSense 11, int
Strongest AI document: AirSense 11, OTA, cloud clinicians
Devices, Noctrix, MatrixCare — digital is not a pillar on the call